Frontlight ResearchEarly access
Trial site
Imeldaziekenhuis
- 8running trials
- 3closed trials
The trials here
What the 11 trials at this site are about, from their registry records.
- Conditions
- Crohn's disease2 trials
- Kidney cancer2 trials
- Ulcerative colitis2 trials
- Aortic aneurysm1 trial
- Atrial fibrillation1 trial
- Diabetic foot ulcer1 trial
- Metastatic breast cancer1 trial
- Multiple sclerosis1 trial
- Stroke1 trial
- Type 1 diabetes1 trial
- Type 2 diabetes1 trial
- Phase
- Phase 32 trials
- Phase 21 trial
- Phase 41 trial
- Status
- Active, not recruiting4 trials
- Recruiting4 trials
- Completed2 trials
- Terminated1 trial
- Lead sponsor
- Universitaire Ziekenhuizen KU Leuven2 trials
- Alfasigma S.p.A.1 trial
- Daiichi Sankyo1 trial
- Eisai Inc.1 trial
- Flen Health1 trial
- and 5 more
Running trials
Recruiting
Recruiting
Active, not recruiting
Recruiting
Active, not recruiting
The Impact of Hybrid Closed-loop Insulin Delivery in Type 1 Diabetes on Glycemic Control and PROMs
Active, not recruiting
Recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Aortic aneurysm1 recruiting
- Atrial fibrillation1 recruiting
- Crohn's disease1 recruiting
- Diabetic foot ulcer1 recruiting
- Stroke1 recruiting
Closed trials
Completed
Terminated
Completed
Site data: ClinicalTrials.govUpdated 15 Nov 2026